A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome

Autor: Rafael de la Torre, Susana de Sola, Magí Farré, Laura Xicota, Aida Cuenca-Royo, Joan Rodriguez, Alba León, Klaus Langohr, María Gomis-González, Gimena Hernandez, Susanna Esteba, Laura del Hoyo, Júdit Sánchez-Gutiérrez, Maria José Cortés, Andrés Ozaita, Josep María Espadaler, Ramón Novell, Rafael Martínez-Leal, Montserrat Milá, Mara Dierssen, Alessandro Principe, Gonzalo Sánchez, Judit Sánchez-Gutiérrez, Laia Roca, Rafasel de la Torre, Montserrat Fitó, Ovideo Banea, María José Cortés, Montserrat Milà, Rafael Maldonado, Arnau Busquets-Garcia, Andres Ozaita, Maria Gomis-González

Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)

Data de publicació electrònica: 25-03-2019 Background & aims: Despite the wide spectrum of experimental compounds tested in clinical trials, there is still no proven pharmacological treatment available for Fragile-X syndrome (FXS), since several ta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48c7ae1e843da1417effc9ab09940c3a
https://hdl.handle.net/2117/183508